432 related articles for article (PubMed ID: 36124721)
41. Nursing home patients with diabetes: prevalence, drug treatment and glycemic control.
Andreassen LM; Sandberg S; Kristensen GB; Sølvik UØ; Kjome RL
Diabetes Res Clin Pract; 2014 Jul; 105(1):102-9. PubMed ID: 24853809
[TBL] [Abstract][Full Text] [Related]
42. The co-formulation of insulin degludec and insulin aspart lowers fasting plasma glucose and rates of confirmed and nocturnal hypoglycaemia, independent of baseline glycated haemoglobin levels, disease duration or body mass index: A pooled meta-analysis of phase III studies in patients with type 2 diabetes.
Haluzík M; Fulcher G; Pieber TR; Bardtrum L; Tutkunkardas D; Rodbard HW
Diabetes Obes Metab; 2018 Jul; 20(7):1585-1592. PubMed ID: 29451706
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of hypoglycemia among a sample of sulfonylurea-treated patients with Type 2 diabetes mellitus in Argentina: The real-life effectiveness and care patterns of diabetes management (RECAP-DM) study.
Gonzalez C; Monti C; Pinzon A; Monsanto H; Ejzykowicz F;
Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):592-602. PubMed ID: 30076124
[TBL] [Abstract][Full Text] [Related]
44. Improved glycemic control with teneligliptin in patients with type 2 diabetes mellitus on hemodialysis: Evaluation by continuous glucose monitoring.
Wada N; Mori K; Nakagawa C; Sawa J; Kumeda Y; Shoji T; Emoto M; Inaba M
J Diabetes Complications; 2015; 29(8):1310-3. PubMed ID: 26298521
[TBL] [Abstract][Full Text] [Related]
45. [Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].
Sato A
Rinsho Byori; 2014 Jan; 62(1):45-52. PubMed ID: 24724426
[TBL] [Abstract][Full Text] [Related]
46. Ketoacidosis at onset of type 1 diabetes is a predictor of long-term glycemic control.
Shalitin S; Fisher S; Yackbovitch-Gavan M; de Vries L; Lazar L; Lebenthal Y; Phillip M
Pediatr Diabetes; 2018 Mar; 19(2):320-328. PubMed ID: 28568379
[TBL] [Abstract][Full Text] [Related]
47. Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels.
Rama Chandran S; A Vigersky R; Thomas A; Lim LL; Ratnasingam J; Tan A; S L Gardner D
Diabetes Technol Ther; 2020 Feb; 22(2):103-111. PubMed ID: 31502876
[No Abstract] [Full Text] [Related]
48. Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009.
de Beaufort CE; Lange K; Swift PG; Aman J; Cameron F; Castano L; Dorchy H; Fisher LK; Hoey H; Kaprio E; Kocova M; Neu A; Njolstad PR; Phillip M; Schoenle E; Robert JJ; Urukami T; Vanelli M; Danne T; Barrett T; Chiarelli F; Aanstoot HJ; Mortensen HB;
Pediatr Diabetes; 2013 Sep; 14(6):422-8. PubMed ID: 22957743
[TBL] [Abstract][Full Text] [Related]
49. Type 2 Diabetes Patients Reach Target Glycemic Control Faster Using IDegLira than Either Insulin Degludec or Liraglutide Given Alone.
Vilsbøll T; Vora J; Jarlov H; Kvist K; Blonde L
Clin Drug Investig; 2016 Apr; 36(4):293-303. PubMed ID: 26894800
[TBL] [Abstract][Full Text] [Related]
50. Effects of structured testing versus routine testing of blood glucose in diabetes self-management: A randomized controlled trial.
Nishimura A; Harashima SI; Fujita Y; Tanaka D; Wang Y; Liu Y; Inagaki N
J Diabetes Complications; 2017 Jan; 31(1):228-233. PubMed ID: 27653670
[TBL] [Abstract][Full Text] [Related]
51. Mismatch between ADA and AGS recommendations for glycated hemoglobin targets for older adults.
Tasci I; Safer U; Naharci I; Sonmez A
Prim Care Diabetes; 2018 Apr; 12(2):192-194. PubMed ID: 29396204
[TBL] [Abstract][Full Text] [Related]
52. Impact of sensor-augmented pump therapy with predictive low-glucose management on hypoglycemia and glycemic control in patients with type 1 diabetes mellitus: 1-year follow-up.
Gómez AM; Henao DC; Taboada LB; Leguizamón G; Rondón MA; Muñoz OM; García-Jaramillo MA; León Vargas FM
Diabetes Metab Syndr; 2019; 13(4):2625-2631. PubMed ID: 31405686
[TBL] [Abstract][Full Text] [Related]
53. Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus.
Pratley RE; Rosenstock J; Heller SR; Sinclair A; Heine RJ; Kiljański J; Brusko CS; Duan R; Festa A
J Diabetes Sci Technol; 2018 Nov; 12(6):1184-1191. PubMed ID: 29893144
[TBL] [Abstract][Full Text] [Related]
54. Association between glycemic control and cardiovascular events in older Japanese adults with diabetes mellitus: An analysis of the Japanese medical administrative database.
Yokote K; Suzuki R; Gouda M; Iijima H; Yamazaki A; Inagaki M
J Diabetes Investig; 2021 Nov; 12(11):2036-2045. PubMed ID: 33988907
[TBL] [Abstract][Full Text] [Related]
55. A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes.
Anjana RM; Kesavadev J; Neeta D; Tiwaskar M; Pradeepa R; Jebarani S; Thangamani S; Sastry NG; Brijendra Kumar S; Ramu M; Gupta PPK; Vignesh J; Chandru S; Kayalvizhi S; Jagdish PS; Uthra SCB; Lovelena M; Jyoti S; Suguna Priya S; Kannan A; Mohan V; Unnikrishnan R
Diabetes Technol Ther; 2017 Sep; 19(9):533-540. PubMed ID: 28930495
[TBL] [Abstract][Full Text] [Related]
56. Beyond HbA1c.
Bloomgarden Z
J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
[TBL] [Abstract][Full Text] [Related]
57. A retrospective cross-sectional study of type 2 diabetes overtreatment in patients admitted to the geriatric ward.
Wojszel ZB; Kasiukiewicz A
BMC Geriatr; 2019 Sep; 19(1):242. PubMed ID: 31477024
[TBL] [Abstract][Full Text] [Related]
58. Liberating A1C goals in older adults may not protect against the risk of hypoglycemia.
Munshi MN; Slyne C; Segal AR; Saul N; Lyons C; Weinger K
J Diabetes Complications; 2017 Jul; 31(7):1197-1199. PubMed ID: 28343792
[TBL] [Abstract][Full Text] [Related]
59. Relationship between electrolytes and glycated hemoglobin among diabetic patients with poor adherence to antidiabetic medications: a cross-sectional study.
Lengeiya F; Mathenge S; Ojola P
Pan Afr Med J; 2024; 47():37. PubMed ID: 38586073
[TBL] [Abstract][Full Text] [Related]
60. Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes: Randomized controlled trial.
Wishah RA; Al-Khawaldeh OA; Albsoul AM
Diabetes Metab Syndr; 2015; 9(4):271-6. PubMed ID: 25301007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
